tion (DD), 0.039 ± 0.032 versus 0.072 ± 0.013 (p = 0.004). There was also a significant stepwise decrease in Ki with increasing DD grade (p = 0.04). Conclusion: Glucose metabolic remodeling is detectable in hypertensive patients before the development of LVH. Furthermore, lower glucose uptake rates are observed in patients with DD. The mechanism for this last finding requires further investigation.
bolic changes become maladaptive could help define a window for aggressive therapy for preventing progression to LVH, LV dysfunction and failure.
Positron emission tomography (PET) imaging identifies metabolic substrate utilization noninvasively [3] . However, myocardial glucose uptake rate estimates may be inaccurate due to partial volume effects and the spillover of radioactivity from the myocardium into the LV blood pool and vice versa. We developed a novel quantitative method, in which the blood input function with spill-over and partial-volume coefficients and the metabolic rate constants in a compartment model are simultaneously estimated from attenuation-corrected, dynamic, gated 2-deoxy-2-[
18 F]fluoro-D-glucose ( 18 F-FDG) PET images of mouse hearts in vivo [4] . Using this refined method in humans, we tested the hypothesis that metabolic remodeling precedes structural changes in HTNinduced LVH.
Materials and Methods
In this prospective study, the electronic medical records of the University of Virginia cardiology clinics between July 2012 and 2013 were reviewed. A cohort of hypertensive patients was recruited, and subjects were classified according to the presence of LVH on transthoracic echocardiography (TTE). Volunteer patients from the same clinic without HTN or LVH on TTE were included as controls.
Patients with the following characteristics were excluded from the study: a history of congenital heart disease or other structural heart disease, prior myocardial infarction, known or suspected infiltrative heart disease, evidence or symptoms of myocardial ischemia, severe valvular disease on echocardiogram, a history of chemotherapy administration in cardiotoxic doses, current corticosteroid therapy, atrial fibrillation or other significant arrhythmia, hypersensitivity to 18 F-FDG and pregnancy or current breastfeeding.
Systemic HTN was defined as a blood pressure ≥ 140/90 mm Hg on two or more separate occasions or antihypertensive medications use for the purpose of blood pressure control [5] .
The study was approved by the Institutional Review Board of the University of Virginia. Informed consent was obtained from all individual participants included in the study.
Demographic Data
The characteristics of patients were collected by chart review, and included: comorbidities, duration, treatment and control of HTN, current cardiac medications and fasting blood glucose levels.
Transthoracic Echocardiography
TTE was performed to determine LV mass, wall thickness, ejection fraction and diastolic function parameters within 6 months of study enrollment. LVH was considered present in the setting of an end-diastolic LV interventricular septum or posterior wall dimension ≥ 1.2 cm measured after closure of the mitral valve. Heart weight (HW) was calculated using the Devereux formula [6] and was divided by the body weight (BW) to compute HW/BW ratios. Diastolic dysfunction (DD) was identified and graded according to the latest American Society of Echocardiography guidelines [7] . The mitral E/A ratio, annular and lateral e′, deceleration time (DT) and the size of the left atrium were calculated to assess diastolic function. DD diagnostic criteria included left atrial enlargement (>34 ml/m 2 ) and septal e′ velocities <8 cm/s. Mild DD was defined as an E/A ratio <0.8 and DT >200 ms. Moderate DD was classified as an E/A ratio of 0.8-1.5 and DT 160-200 ms. Severe DD was defined as an E/A ratio ≥ 2 and DT <160 ms.
F-FDG Positron Emission Tomography
PET imaging was performed after an overnight fast. We aimed to determine glucose uptake under normal, steady-state conditions rather than facilitating glucose uptake with a hyperinsulinemic euglycemic clamp. All patients received a computed tomographic (CT) scan for attenuation correction, followed by a 30-min dynamic PET scan with cardiac gating on a Siemens Biograph mCT PET-CT scanner. Imaging was initiated a few seconds before the slow administration of 10-15 mCi intravenous 18 F-FDG over 30 s. Images were reconstructed using an iterative reconstruction algorithm with the following dynamic frames: 12 frames of 10 s each, 8 of 30 s, 8 of 60 s, 2 of 180 s and 2 of 300 s. Regions of interest were drawn in the areas corresponding to the LV blood pool and the myocardium (one region corresponding to the left anterior descending artery, left circumflex artery and right coronary artery), and average time activity curves were generated. A novel model [4] was used to determine the global rate of myocardial FDG uptake, Ki (ml/min/g).
Statistical Analyses
Continuous variables are given as means ± standard deviation and were compared using ANOVA with Tukey's Studentized range testing. Categorical variables are given as percentages and were compared using the χ 2 or Fisher's exact test when appropriate. SigmaStat 3.0 software was used for statistical analysis. A p value of <0.05 was considered statistically significant.
Results
The study population included 31 patients: 11 with HTN without LVH (HTN no LVH), 9 with HTN and LVH (HTN + LVH) and 11 controls with neither LVH nor HTN (controls). The general characteristics of the patient population are presented in table 1 . The mean age was 53 ± 9 years, with women comprising 61%. The mean age was lower in the controls compared with the hypertensive groups. Gender distribution was similar in the controls and HTN no LVH group (54% each), but the percentage of females was higher in the HTN + LVH group (78%, p < 0.001). Heart rate was significantly lower in the controls. No significant differences in comorbid conditions (hyperlipidemia, smoking and stroke), fasting hyperglycemia, BMI or BSA were found between 
TTE Findings
All patients had normal baseline LV systolic function with an ejection fraction of 60-65% on TTE. The mean septal wall thickness differed significantly between the groups (p = 0.009; table 1 ); it was higher in the HTN + LVH group than in the controls (11.5 ± 2.9 mm vs. 7.9 ± 2.3 mm, p = 0.006). The mean wall thickness for the HTN patients did not differ significantly from the controls (p = 0.523), but was significantly lower than in the HTN + LVH group (p < 0.05; fig. 1 ). The mean HW/BW ratio was also greater in the HTN + LVH (0.96 ± 0.2 g/lb) than in the HTN group (0.6 ± 0.3 g/lb, p = 0.021) and the controls (0.67 ± 0.3 g/lb, p = 0.034). There was no significant difference in HW/BW ratios between the HTN group and the controls (p = 0.809; fig. 2 ).
PET Metabolic Imaging
The mean Ki value (ml/min/g) for glucose uptake in the 3 groups differed significantly (p < 0.001). It was higher in the HTN group (0.10 ± 0.032) than in the HTN + LVH group (0.024 ± 0.011, p < 0.001) and controls (0.067 ± 0.013, p = 0.003). The mean Ki was significantly lower in the HTN + LVH group when compared with the control group (p < 0.001; fig. 3 ).
Diastolic Function and Ki
Diastolic function was assessed by echocardiography in 28 of 31 subjects (90.3%). Data were unavailable in 1 control subject, 2 HTN no LVH patients and 1 patient with HTN + LVH. Overall, the mean Ki was significantly lower in the patients with DD (0.039 ± 0.032 vs. 0.072 ± 0.013, p = 0.004). There was a significant stepwise decrease in Ki (p = 0.04) as the grade of DD increased ( fig. 4 ) . Diastolic function was normal in all control subjects. DD was present in 5/9 (55.6%) of the HTN no LVH group. One of these Values are expressed as mean ± SD or n (%), unless otherwise indicated. ACE = Angiotensin-converting enzyme; ARB = angiotensin receptor blocker; HCTZ = hydrochlorothiazide; n.s. = not significant. 160 subjects had moderate DD and the rest had mild DD. However, there was no significant difference in Ki in the HTN group between patients with and without DD (0.072 ± 0.032 vs. 0.096 ± 0.039, p = 0.304). DD was present in all patients with HTN + LVH. One of the subjects had severe DD, 2 had moderate DD and the rest had mild DD.
Discussion
Our findings indicate that glucose uptake increases in patients with HTN but no LVH when compared to control subjects. These results are consistent with previous findings in animal models of LVH [4, 8, 9] , and they sug- Comparison of HW/BW in g/lbs in the study groups. The HTN + LVH group exhibited significantly greater HW/BW ratios compared to the control and HTN groups. Data are shown as mean ± SE. * p < 0.05. Fig. 3 . a Measured rates of myocardial FDG uptake (Ki). Representative FDG PET axial slices of the heart in the 3 patient populations at the last time frame. The limited contrast between the LV cavity and myocardium in the HTN + LVH image is due to the minimal FDG uptake in the myocardium, leading to limited differentiation from background blood pool levels. This finding is not due to poor image quality. Arrows indicate the myocardium and the blood pool in the HTN + LVH image. b The rate of FDG uptake in the HTN group is significantly higher than in the controls and in the HTN + LVH group (*p < 0.05). We also observe a significantly greater rate of FDG uptake in the control group than in the HTN + LVH group ( gest that metabolic changes in the human heart precede the development of structural remodeling in the form of LVH. Although derangements in fatty acid metabolism in hypertensive heart disease have been previously studied [10] , this is the first study that addresses myocardial glucose uptake using 18 F-FDG PET in human subjects with HTN prior to the development of LVH. The increase in Ki in early HTN could be an adaptive response to maintain function with no change in LV structure. It is consistent with our previous finding that glucose metabolic remodeling occurs in the heart of hypertensive rabbits [11] . Subsequent studies with serial measurements in the same patient population would be the next step to take in order to further understand metabolic remodeling in the human heart.
An interesting and unexpected finding of our study was the decreased 18 F-FDG uptake rate in patients with HTN + LVH compared to the HTN no LVH patients. The presence and severity of DD correlates and may explain, at least partially, this finding. Those with DD in the HTN no LVH group had a lower Ki, but this did not reach statistical significance. Furthermore, there was a stepwise decrease in Ki with increasing DD grade in all patients with HTN. The pathophysiology for this finding is unclear and will require further studies. A possible explanation could be increased levels of myocardial fibrosis in the HTN + LVH patients, due to structural remodeling ( fig. 1 ,  2 ) and resulting in severe DD and lower Ki. Other potential explanations for this finding are differences according to gender in the metabolic and structural remodeling induced by HTN [12] and the presence of diabetic patients in the HTN + LVH group. Diabetes may affect 18 F-FDG uptake through downregulation of the transcription factor myocyte enhancer factor 2c and its controlled genes, including the glucose transporter 4 [13] . There is a growing body of literature, including published work from our group and others, showing that insulin resistance protects the heart from fuel overload [14] [15] [16] . In addition to diabetes, the duration of HTN may play a role in the reduced myocardial glucose uptake in the LVH population. In addition, based on previous findings from the coinvestigators' lab [17] , there is a negative correlation in the human heart between plasma free fatty acids and diastolic function.
Beta blockers can attenuate myocardial FDG uptake, as we observed in our recent animal studies [4] . However, in this study, it is unlikely that differences in treatment with beta blockers could explain the findings, as there was no significant difference in the percentage of patients treated with these drugs in the HTN and HTN + LVH groups ( table 1 ) . Furthermore, in patients with idiopathic dilated cardiomyopathy, the heart changes from predominantly fat metabolism to glucose metabolism in response to beta-blocker treatment [18, 19] . These reports make the issue of substrate preference in human heart muscle even more complex.
Conclusions
Metabolic remodeling of the left ventricle as indicated by an increased rate of 18 F-FDG uptake in hypertensive patients precedes the development of structural remodeling as assessed by LVH. This finding may encourage protocols for the noninvasive detection of early metabolic changes to indicate early aggressive therapy for preventing disease progression. Hypertensive subjects with LVH had an unexpected decreased rate of 18 F-FDG uptake, and this finding appears to correlate with the decreased uptake observed in subjects with DD. Further research is warranted to identify the underlying mechanisms of this finding. There was a significant stepwise decrease in Ki as the DD grade increased (p = 0.04). Diastolic function was normal in all control subjects. DD was present in 5/9 (55.6%) of those with HTN and no LVH. One of these subjects had moderate DD, and the remainder had mild DD. DD was present in all patients with HTN + LVH. One of these subjects had severe DD, 2 had moderate DD and 5 had mild DD. Data are shown as mean ± SE. 
